PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $194,000 | -32.9% | 27,735 | -12.0% | 0.02% | -37.5% |
| Q2 2021 | $289,000 | +112.5% | 31,530 | +134.6% | 0.02% | +166.7% |
| Q3 2020 | $136,000 | -79.6% | 13,441 | -83.0% | 0.01% | -81.2% |
| Q1 2020 | $667,000 | +152.7% | 79,050 | +161.9% | 0.05% | +200.0% |
| Q4 2019 | $264,000 | -49.4% | 30,187 | -37.8% | 0.02% | -64.4% |
| Q3 2019 | $522,000 | -79.4% | 48,506 | -25.9% | 0.04% | -75.0% |
| Q1 2019 | $2,538,000 | +125.6% | 65,430 | +166.7% | 0.18% | +111.8% |
| Q3 2018 | $1,125,000 | +78.0% | 24,529 | +164.3% | 0.08% | +93.2% |
| Q1 2018 | $632,000 | +149.8% | 9,281 | +220.0% | 0.04% | -36.2% |
| Q2 2017 | $253,000 | -57.3% | 2,900 | -85.0% | 0.07% | -26.6% |
| Q4 2016 | $593,000 | -46.2% | 19,326 | +17.6% | 0.09% | -61.8% |
| Q3 2016 | $1,102,000 | +15.2% | 16,429 | -49.6% | 0.25% | +119.6% |
| Q1 2016 | $957,000 | -24.8% | 32,600 | +92.9% | 0.11% | +1.8% |
| Q3 2015 | $1,273,000 | +356.3% | 16,900 | +604.2% | 0.11% | +254.8% |
| Q2 2015 | $279,000 | – | 2,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |